foxo4-dri peptide senolytic mice 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4 - an overview |
FOXO4 an overview ScienceDirect Topics Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics The Journal of Prevention of Alzheimer's Disease Springer Nature Link Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS FOXO4 DRI FOXO4 p53 Peptide Peptagon
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





